Literature DB >> 27913854

The role of macromolecules in the formation of kidney stones.

Jeffrey D Rimer1, Ann M Kolbach-Mandel2, Michael D Ward3, Jeffrey A Wesson4.   

Abstract

The formation of crystal aggregates, one of the critical processes in kidney stone pathogenesis, involves interactions between crystals (predominantly calcium oxalate monohydrate, COM) and urinary constituents (e.g., proteins), which serve as an adhesive "glue" between crystals in stones. To develop a better understanding of the protein-crystal interactions that lead to crystal aggregation, we have measured the effect of model proteins on bulk COM crystal properties as well as their adsorption on crystal surfaces using three synthetic polyanions: poly(aspartic acid) (polyD), poly(glutamic acid) (polyE), and poly(acrylic acid) (polyAA). These anionic macromolecules reduced the amount of COM crystal aggregation in bulk solution to an extent similar to that observed for mixture of proteins from normal urine, with little difference between the polymers. In contrast, the polymers exhibited differences in measures of COM crystal growth. Polycations such as poly(arginine) (polyR) and poly(lysine) (polyK) reduced aggregation weakly and exerted negligible effects on crystal growth. All polyions were found to associate with COM crystal surfaces, as evidenced by changes in the zeta potential of COM crystals in electrophoretic mobility measurements. On the other hand, COM aggregation and possibly growth can be promoted by many binary mixtures of polycations and polyanions, which appeared to be mediated by polymer aggregate formation rather than loss of crystal charge stabilization. Similarly, crystal aggregation promotion behavior can be driven by forming aggregates of weakly charged polyanions, like Tamm-Horsfall protein, suggesting that polymer (protein) aggregation may play a critical role in stone formation. Sensitivity of polyanion-COM crystal surface interactions to the chemical composition of polymer side groups were demonstrated by large differences in crystal aggregation behavior between polyD and polyE, which correlated with atomic force microscopy (AFM) measurements of growth inhibition on various COM surfaces and chemical force microscopy (CFM) measurements of unbinding forces between COM crystal surfaces and AFM tips decorated with either carboxylate or amidinium moieties (mimicking polyanion and polyR side chains, respectively). The lack of strong interaction for polyE at the COM (100) surface compared to polyD appeared to be the critical difference. Finally, the simultaneous presence of polyanions and polycations appeared to alter the ability of polycations to mediate unbinding forces in CFM and promote crystal growth. In summary, polyanions strongly associated with COM surfaces and influenced crystallization, while polycations did not, though important differences were observed based on the physicochemical properties of polyanions. Observations suggest that COM aggregation with both polyanion-polycation mixtures and weakly charged polyanions is promoted by polymer aggregate formation, which plays a critical role in bridging crystal surfaces.

Entities:  

Keywords:  Adhesion; Aggregation; Atomic force microscopy; Calcium oxalate; Kidney stone; Polyelectrolyte

Mesh:

Substances:

Year:  2016        PMID: 27913854      PMCID: PMC5253101          DOI: 10.1007/s00240-016-0948-8

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  76 in total

1.  Proteomic study of renal uric acid stone.

Authors:  Yeong-Chin Jou; Chiung-Yao Fang; Syue-Yi Chen; Fang-Hung Chen; Ming-Chin Cheng; Cheng-Huang Shen; Li-Wen Liao; Yuh-Shyan Tsai
Journal:  Urology       Date:  2012-04-17       Impact factor: 2.649

2.  Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.

Authors:  Mayur Danny I Gohel; Daisy K Y Shum; Po Chor Tam
Journal:  Carbohydr Res       Date:  2006-11-07       Impact factor: 2.104

3.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis.

Authors:  N G Anderson; N L Anderson; S L Tollaksen
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

5.  Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.

Authors:  Vivek Kumar; Gerard Farell; Sergio Deganello; John C Lieske
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

Review 6.  Glycosaminoglycans as inhibitors of stone formation.

Authors:  J D Sallis
Journal:  Miner Electrolyte Metab       Date:  1987

Review 7.  Use of traditional Chinese medicine in the management of urinary stone disease.

Authors:  Ricardo Miyaoka; Manoj Monga
Journal:  Int Braz J Urol       Date:  2009 Jul-Aug       Impact factor: 1.541

8.  Adsorption of DNA to mica mediated by divalent counterions: a theoretical and experimental study.

Authors:  David Pastré; Olivier Piétrement; Stéphane Fusil; Fabrice Landousy; Josette Jeusset; Marie-Odile David; Loïc Hamon; Eric Le Cam; Alain Zozime
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

9.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

10.  Diversity in protein profiles of individual calcium oxalate kidney stones.

Authors:  Nobuaki Okumura; Masao Tsujihata; Chikahiro Momohara; Iwao Yoshioka; Kouzou Suto; Norio Nonomura; Akihiko Okuyama; Toshifumi Takao
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  14 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

Review 2.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

3.  Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?

Authors:  Jeffrey A Wesson; Ann M Kolbach-Mandel; Brian R Hoffmann; Carley Davis; Neil S Mandel
Journal:  Urolithiasis       Date:  2019-04-16       Impact factor: 3.436

4.  Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes.

Authors:  Jeffrey A Wesson; Roman Zenka; Jody Lulich; Jessica Eisenhauer; Carley Davis
Journal:  Urolithiasis       Date:  2022-09-30       Impact factor: 2.861

Review 5.  Human kidney stones: a natural record of universal biomineralization.

Authors:  Mayandi Sivaguru; Jessica J Saw; Elena M Wilson; John C Lieske; Amy E Krambeck; James C Williams; Michael F Romero; Kyle W Fouke; Matthew W Curtis; Jamie L Kear-Scott; Nicholas Chia; Bruce W Fouke
Journal:  Nat Rev Urol       Date:  2021-05-24       Impact factor: 14.432

6.  Exploring mechanisms of protein influence on calcium oxalate kidney stone formation.

Authors:  Garrett K Berger; Jessica Eisenhauer; Andrew Vallejos; Brian Hoffmann; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2021-02-15       Impact factor: 2.861

7.  Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.

Authors:  Stefanie Steiger; Julia Felicitas Grill; Qiuyue Ma; Tobias Bäuerle; Jutta Jordan; Michaela Smolle; Claudia Böhland; Maciej Lech; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

8.  LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.

Authors:  Martino Marangella; Michele Petrarulo; Corrado Vitale; Piergiuseppe Daniele; Silvio Sammartano
Journal:  Urolithiasis       Date:  2020-11-27       Impact factor: 3.436

Review 9.  Influences of Crystal Anisotropy in Pharmaceutical Process Development.

Authors:  Eftychios Hadjittofis; Mark Antonin Isbell; Vikram Karde; Sophia Varghese; Chinmay Ghoroi; Jerry Y Y Heng
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

10.  Hydroxyl-rich macromolecules enable the bio-inspired synthesis of single crystal nanocomposites.

Authors:  Yi-Yeoun Kim; Robert Darkins; Alexander Broad; Alexander N Kulak; Mark A Holden; Ouassef Nahi; Steven P Armes; Chiu C Tang; Rebecca F Thompson; Frederic Marin; Dorothy M Duffy; Fiona C Meldrum
Journal:  Nat Commun       Date:  2019-12-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.